In March 15th, the Guangdong provincial drug exchange center issued a notice that a few days ago, the New Coronavirus (2019-nCoV) test reagent alliance regional group procurement with quantity (procurement document number: GDYJHCDL202102) selected the enterprise Guangzhou Wondfo Biotech Co.Ltd(300482) . The price of New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) (national standard 20203400830) is adjusted to 9.8 yuan per person. The notice shows that the relevant products have been adjusted according to the application price of the selected enterprise.
Since April 2021, the Guangdong drug exchange center has carried out the procurement of New Coronavirus test reagent alliance regional group, and the antigen detection reagent has also been included in the COVID-19 detection reagent range with quantity purchase.
According to the purchasing document of the New Coronavirus (2019-nCoV) testing reagent alliance regional group, the main body of the procurement in the alliance area is the public medical institutions and disease control institutions that New Coronavirus detects in 11 provinces (municipalities and autonomous regions) such as Guangdong, Jiangxi, Henan, Hunan, Guangxi, Hainan, Chongqing, Guizhou, Yunnan, Gansu, and Qinghai provinces (municipalities and autonomous regions). At that time, only Guangzhou Wondfo Biotech Co.Ltd(300482) carried out volume purchase and reported the volume, and finally won the election with 16.80 yuan / person.
